Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
It is not recommended for individuals with severe liver, kidney, or heart disease without prior medical clearance
You want to avoid extremes
Key benefits Why people compare it 1 Increases intracellular NAD+ approximately 2-fold by blocking NNMT-mediated nicotinamide diversion 2 Activates SIRT1 longevity pathway via NAD+-dependent deacetylase activation 3 Reduces adipocyte size by approximately 40% with decreased DGAT1/DGAT2 expression 4 Produces 7% body weight reduction in DIO mice without appetite suppression 5 Improves glucose tolerance and reduces hepatic steatosis in preclinical obesity models 6 Preserves SAM levels for improved methylation capacity across tissues 7 Orally bioavailable small molecule (173 Da) requiring no injection or reconstitution 8 Shifts adipocyte metabolism from lipid storage to fatty acid oxidation (CPT1A/ACADM upregulation) Deep research About 5-Amino-1MQ 5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) with a molecular weight of approximately 173 Da and a CAS registry number of 42675-71-0
OHalloran, Daniel Carey, Deirdre OConnor, Rose A
For smoother blood concentration and reduced peak-related side effects, some users opt to split the dose into bi-weekly injections (every 3.5 days)
Later, when I returned to the site, all GLP-1 options had been removed without notice
